GlassScriptPhysician profile
Jacob Wang
NPI 1487064663
$162,171.60
in general payments reported to CMS, 2019-2025
29 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $1,286 · 2021: $1,852 · 2022: $5,592 · 2023: $12K · 2024: $48K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $77K · Food and Beverage: $19K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $77,359.38 |
| Food and Beverage | $18,880.58 |
| Travel and Lodging | $15,918.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,825.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $94,969.05 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $20,792.01 | 2019-2020 | |
| Globus Medical, INC. | $18,155.07 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Abbott Laboratories | $8,941.02 | 2019-2025 | Proclaim, Eterna, Infinity |
| Nevro Corp. | $6,801.32 | 2019-2024 | Senza |
| Boston Scientific Corporation | $6,782.02 | 2019-2024 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $1,284.80 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Vertos Medical, INC. | $922.54 | 2020-2024 | Mild Device Kit |
| Painteq LLC | $633.62 | 2022-2024 | Painteq |
| Spr Therapeutics, INC | $627.91 | 2019-2023 | Sprint Pns System |
| Relievant Medsystems, INC. | $539.45 | 2021-2023 | Intracept |
| Biotronik Nro, INC. | $416.28 | 2025 | Prospera |
| Stryker Corporation | $369.41 | 2024-2025 | Mild Device Kit, Optablate |
| Stimwave Technologies Incorporated | $143.91 | 2019 | |
| Curonix LLC | $135.34 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $108.25 | 2019-2021 | |
| Forte Bio-Pharma LLC | $104.59 | 2019-2021 | |
| Tersera Therapeutics LLC | $100.00 | 2019 | |
| Nalu Medical, INC. | $82.57 | 2021-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $56.82 | 2019-2020 | |
| Almatica Pharma LLC | $41.45 | 2021 | |
| Allergan, INC. | $34.41 | 2019-2020 | |
| Lilly USA, LLC | $23.80 | 2021 | |
| Pfizer INC. | $22.96 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $22.00 | 2025 | |
| Mml US, INC. | $18.48 | 2023 | Reactiv8 |
| Averitas Pharma INC. | $15.20 | 2024 | Qutenza |
| Acelrx Pharmaceuticals, INC. | $14.14 | 2019 | |
| Avanos Medical | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.